GlassScriptPhysician profile
Kartik Kumar
NPI 1356736912
$13,561.10
in general payments reported to CMS, 2019-2025
48 companies · $1,446 in 2025
The $1,446 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $616 · 2020: $1,702 · 2021: $3,992 · 2022: $3,127 · 2023: $1,569 · 2024: $1,110 · 2025: $1,446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,084 · Education: $40.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,084.06 |
| Education | $40.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $2,159.85 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $2,123.39 | 2019-2025 | Avvigo Guidance System, Watchman Flx, Wolverine Coronary Cutting Balloon |
| Amgen INC. | $1,190.91 | 2020-2025 | Repatha, Evenity, Prolia |
| Abbott Laboratories | $844.61 | 2021-2025 | Ultreon, Aveir, Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $696.83 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $671.72 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $645.74 | 2020-2025 | Farxiga, Wainua |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $622.69 | 2019-2023 | Lifevest |
| Cardiovascular Systems INC. | $582.84 | 2020-2021 | |
| Biotronik INC. | $514.28 | 2021-2022 | |
| Terumo Medical Corporation | $481.72 | 2021-2022 | |
| Cordis US Corp. | $302.36 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $258.87 | 2019-2025 | Camzyos, Eliquis |
| Teleflex LLC | $253.98 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $249.94 | 2023-2025 | Jardiance, Synjardy, Tradjenta |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $221.69 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $157.46 | 2022-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $125.74 | 2024 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $122.97 | 2021 | |
| Elutia, INC. | $120.91 | 2021 | |
| Edwards Lifesciences Corporation | $103.65 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Merck Sharp & Dohme LLC | $98.37 | 2022-2023 | Verquvo |
| Baxter Healthcare | $82.55 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Alnylam Pharmaceuticals INC. | $79.19 | 2020-2025 | Amvuttra |
| Abiomed | $74.58 | 2025 | |
| Philips North America LLC | $72.45 | 2021-2022 | |
| Inspire Medical Systems, INC. | $71.09 | 2025 | Inspire |
| Esperion Therapeutics, INC. | $68.39 | 2025 | Nexletol |
| Kiniksa Pharmaceuticals, LTD. | $65.99 | 2021-2023 | Arcalyst |
| Cagent Vascular INC | $58.25 | 2022 | |
| Medtronic, INC. | $51.23 | 2021-2022 | |
| Lexicon Pharmaceuticals, INC. | $47.37 | 2024 | |
| Medicomp INC | $32.86 | 2024 | Telepatch Cardiac Monitor |
| Heartflow, INC. | $29.57 | 2025 | |
| Asahi Intecc USA, INC. | $27.37 | 2022 | |
| Ionis Pharmaceuticals, INC. | $25.03 | 2025 | Tryngolza |
| Kestra Medical Technology Services, INC. | $24.64 | 2022 | |
| W. L. Gore & Associates, INC. | $24.47 | 2021 | |
| Bracco Diagnostics INC. | $22.76 | 2019 | |
| Akcea Therapeutics, INC. | $22.64 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $21.94 | 2024 | Evkeeza |
| Dexcom, INC. | $19.01 | 2024 | Dexcom G6 Transmitter |
| Scpharmaceuticals INC. | $18.92 | 2025 | |
| Novo Nordisk INC | $15.40 | 2024 | Rybelsus, Ozempic |
| Echosens North America, INC. | $14.13 | 2025 | Fibroscan |
| Chiesi USA, INC. | $14.00 | 2023 | Kengreal, Cleviprex |
| Lilly USA, LLC | $13.78 | 2024 | Jardiance, Zepbound |
| Medtronic Vascular, INC. | $12.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kartik Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.